- Home
- NET vs MDT Comparison
NET vs MDT Comparison
Compare NET & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NET | MDT |
|---|---|---|
| Founded | 2009 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.3B | 107.0B |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NET | MDT |
|---|---|---|
| Price | $360.60 | $87.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 34 | 28 |
| Target Price | ★ $336.81 | $104.83 |
| AVG Volume (30 Days) | 2.6M | ★ 11.3M |
| Earning Date | 10-29-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 3.33% |
| EPS Growth | N/A | ★ 3.32 |
| EPS | N/A | ★ 1.14 |
| Revenue | $2,167,937,000.00 | ★ $36,364,000,000.00 |
| Revenue This Year | $32.46 | $7.42 |
| Revenue Next Year | $28.71 | $3.42 |
| P/E Ratio | ★ N/A | $75.82 |
| Revenue Growth | ★ 29.85 | 8.43 |
| 52 Week Low | $158.83 | $73.31 |
| 52 Week High | $367.43 | $106.33 |
Technical Indicators
Market Signals| Indicator | NET | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 64.39 | 42.81 |
| Support Level | $163.46 | $85.35 |
| Resistance Level | $367.43 | $89.00 |
| Average True Range (ATR) | 16.35 | 1.84 |
| MACD | 0.78 | -0.64 |
| Stochastic Oscillator | 87.34 | 28.59 |
Price Performance
Historical ComparisonAbout NET Cloudflare Inc.
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, builds on this infrastructure by enabling clients to deploy and run code without the need to manage or maintain servers.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.